✦ LIBER ✦

Prostate-specific antigen velocity (PSAV) risk count improves the specificity of screening for clinically significant prostate cancer

✍ Scribed by Stacy Loeb; E. Jeffrey Metter; Donghui Kan; Kimberly A. Roehl; William J. Catalona

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PROSTATE-SPECIFIC ANTIGEN VELOCITY (PSAV

✍ H. Ballentine Carter 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB

Re: Prostate-Specific Antigen Velocity (

✍ Walsh, Patrick C. 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 122 KB

Is Prostate-Specific Antigen Velocity Se

✍ Tineke Wolters; Monique J. Roobol; Chris H. Bangma; Fritz H. Schröder 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 278 KB

Re: Is Prostate-Specific Antigen Velocit

✍ Vincenzo Scattoni 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Editorial Comment on: Is Prostate-Specif

✍ Martha K. Terris 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Prostate-specific antigen velocity based

✍ Ping Tang; Leon Sun; Matthew A. Uhlman; Cary N. Robertson; Thomas J. Polascik; J 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 296 KB